NASDAQ:NBSE
USD
0.43
- (2.4%)
NEUBASE THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 18 April 2024 GMT-4
USD 0.430
- (2.4%)
End of Day: 18 April 2024 GMT-4
Industry: Biotechnology
Quote
Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-
Company Info
more
NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platf...
Key Ratios
more
Income
more
Total Revenues (USD, MM)
-
Net Income (USD, MM)
-
Net Margin
-
Balance Sheet
more
Total Assets (USD, MM)
-
Total Liabilities (USD, MM)
-
Book Value Per Share
-
Cash Flow
more
Operations (USD, MM)
-
Investing (USD, MM)
-
Financing (USD, MM)
-
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
